SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 7.76 |
| Enterprise Value ($M) | -8.63 |
| Book Value ($M) | 40.25 |
| Book Value / Share | 5.86 |
| Price / Book | 0.19 |
| NCAV ($M) | 13.39 |
| NCAV / Share | 1.95 |
| Price / NCAV | 0.58 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.50 |
| Return on Assets (ROA) | 0.28 |
| Return on Equity (ROE) | 0.37 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 14.20 |
| Current Ratio | 14.20 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 16.96 |
| Assets | 43.83 |
| Liabilities | 3.58 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Ayrton Capital LLC | 9.90 | -19.05 | |
| 13G/A | Intracoastal Capital, Llc | 9.99 | -12.14 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 353 | 13,353 | 2.64 | |
| 394 | 22,800 | 1.73 | |
| 707 | 6,147 | 11.50 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PDSB – PDS Biotechnology Corporation | PHIO – Phio Pharmaceuticals Corp. |
| PLUR – Pluri Inc. | PMN – ProMIS Neurosciences, Inc. |
| PRFX – PainReform Ltd. |
Financial data and stock pages provided by
Fintel.io